SCOPE 2026 Testimonials

Fifteen years ago, the buzz at SCOPE was about digitizing paper processes. Today, we're talking about seamlessly integrated platforms, patient-centric design, and leveraging cutting-edge AI to accelerate discovery. But through all these shifts, one constant has remained — the shared commitment to getting new treatments to patients faster and more safely.

This conference has been a staple for Praxis over the years, and the friendships and business relationships that have helped shape our industry are unmatched.

CEO, Crowley Webb and Praxis

It’s been one of the most engaging, productive and network infused weeks in my tenure at this brilliant event of innovators, pioneers and drivers of clinical research.

CEO, ISPEP

Feeling energized after attending #SCOPEsummit (Summit for Clinical Ops Executives) in Orlando this week! My team and I were surrounded by passionate professionals committed to advancing the future of clinical research by putting the patient first.

Director, Research Operations, Incyte

Leaving #SCOPESummit feeling energized, exhausted, encouraged, and truly inspired. How fortunate we are to gather with thousands of the brightest minds in our industry—to reconnect with former cubicle mates now leading as VPs, and to spend time learning, brainstorming, and building new relationships that have the potential to stand the test of time.

My biggest takeaway this year? The conversations shifted. Less “let me tell you why I’m the best” and more “let’s talk about how we can create something better together.” Vendors collaborating with vendors, sponsors prioritizing patient engagement beyond the study through education, CROs seeking meaningful partnerships with community-based sites—and a collective excitement about what’s ahead.

My challenge to my team—and yours—is this: now the real work begins. Take the small, intentional actions today that will lead to the meaningful change you’ll be talking about at next year’s conference.

I’m proud to be part of this industry alongside all of you, grateful for the opportunity to make a meaningful difference in patients’ lives, and truly honored to walk this journey with my Walgreens Clinical Trials team. Together, we’re building something that matters—and this is only the beginning.

Interim Head of Commercial Development, RWE Clinical Trials, Walgreens Boots Alliance

Four years in, and #SCOPESummit felt like a family reunion. Escaping snow-covered terrain to reconnect with colleagues-turned-friends from around the world in Orlando? That's what it's all about.

Solution Architect Director, Datacubed Health

It was so great meeting everyone at my first trip to #SCOPEsummit! A few things stood out to me...

First, a standout community and commitment to an authentic exchange of progress, setbacks, and ideas for the betterment of everybody.

Second, driven by precision medicine, we have truly entered the biospecimen moment. There is a palpable sense that the importance of biospecimen ops is finally being recognized by leaders for its strategic importance to trial success. Sample ops leaders and teams feel seen, and are enthusiastically seizing the opportunity to build community, collaborate, and innovate.

Lastly, we are going to see some of the most exciting and transformational AI applications in trial ops in the next 12-24 months. While AI applications in exploratory R&D are rightfully gaining spotlight, the fragmented data and manual processes across clinical trial operations present a far more immediate opportunity for ROI.

Director of Business Development, QuartzBio, part of Precision for Medicine

Keepin it real with Real Patients — the way for the savviest in our industry to get real patient insights!

Founder, Advisor, Clinical Innovation Partners; Co-Chair, Decentralized Trials & Research Alliance (DTRA)

SCOPE Summit brings together some of the most progressive and innovative minds in clinical research. Looking forward to reconnecting with the patient-focused community and learning about all the ongoing work to accelerate clinical trials and get new therapies to patients faster.

CEO, ISPEP

The variety of quality presentations were impressive but the camaraderie and high energy made it exceptional. The best moments weren’t just on stage—they were in the hallway problem-solving sessions, the candid sponsor–CRO–site discussions, and the shared commitment to raising the bar for trial delivery.

And personally? It was a joy to reconnect with old friends and respected colleagues—and just as exciting to make new connections with people who clearly care about doing this work better. Grateful for the ideas, the laughs, and the momentum. Already looking forward to what we build next and SCOPE 2027.

If you’re looking for me at SCOPE 2027, follow the sound of a big, happy laugh—then come say hello.

CEO, Choice ClinOps; Fractional Executive – Global Clinical Trial Operations (Cancer & Rare Disease Clinical Trials)

Leaving the 2026 #SCOPESummit feeling energized after connecting with industry leaders and exchanging ideas on how we can advance patient care through excellence in clinical trial execution. I’m so proud of our Drug Development Portfolio and Program Management team who had a strong presence showcasing our innovative solutions aimed at:

• Advancing Data Analytics with Agentic AI → Demonstrating how AI can drive faster decision-making in clinical trials
• Improving productivity through Clinical Data Flow Digitization and document automation
• Strengthening Patient Insights into Protocol Development → Advocating for patient-centered approaches in crafting trial protocols

A special thank you to our IT colleagues for their invaluable partnership in this endeavor. Together, we are staying ahead of the curve in implementing transformative changes for the patients we serve.

Vice President, Drug Development Portfolio & Program Management, Bristol Myers Squibb

Had the pleasure of attending the SCOPE Summit in Orlando this week. It was fantastic connecting with industry leaders across the life sciences, exchanging ideas, and discussing new ways to advance research, innovation, and operational excellence. Thank you to everyone who made the conversations so valuable.

Senior Director, Clinical Operations, Aquestive Therapeutics

Thank you for organizing such a fantastic event. It was a great opportunity to learn from peers and engage with the community.

Senior Director, Group Lead Generative AI Products, Pfizer Inc.

What stood out most was the energy. The openness to talk. The willingness to rethink how things have been done. Looking forward to my next time at SCOPE.

Visiting Researcher, Harvard University

SCOPE continues to be one of the few forums where these conversations happen with complete transparency. The opportunity now is not recognizing the problems, but operationalizing the solutions.

Business Development Manager, Clinical, OMNI CRS

There was a real sense of energy, positivity, and collaboration across the four days. It was superb meeting with so many key stakeholders across the clinical research.

Brilliant to reconnect with familiar contacts, building new relationships, and talk about how the industry is evolving.

CEO & Founder, APX Life Sciences

SCOPE Summit 2026 is officially underway; and the PatientWing team is here! The conversations are flowing, the energy is high, and the momentum around better, faster, more human clinical trials is real. From patient-first enrollment to smarter use of data and AI, this week is all about moving the industry forward — together.

PatientWing

SCOPE…is…one of the most active networking environments in the industry…We have attended SCOPE for several years in a row. Each year, the conversations get sharper, faster, and more urgent as clinical research evolves. Teams are under pressure to deliver more with less. At the same time, patients are demanding better experiences and more transparency. That is exactly why we value SCOPE. It is where clinical research connects.

Vistatec Life Sciences

I was fascinated with the genesis of the SCOPE conference, a true entrepreneurial success story. A hearty congratulations on building a best-in-class conference, with a loyal/dedicated attendee following. Impressive!

President & CEO, Biogen and Proximity Health Solutions

First - thank you for the amazing platform for us to share patient perspectives. It was truly an honor to get to ask the superstars to help create some new awareness in the audience.

I loved this conversation so much - and it meant the world to me to be able to moderate it! Stating the obvious, I'll be there for you and the SCOPE team anyway you need me.

VP Programs & Initiatives, Decentralized Trials & Research Alliance (DTRA)

It really is amazing how far SCOPE has come over the years, and I am excited about the inaugural SCOPE X! SCOPE was truly a phenomenal meeting!

Executive Director, Global Trial Optimization/Global Clinical Trial Operations, Merck

I just want to let you know that I really do appreciate all of the work that goes into making the Scope conference special and quite extraordinary. It’s one that I look forward to all year and I always learn a lot and meet great people. Also you do a great job on the creature comforts and making sure everyone has fuel, hydration and socialization to look forward to. Lastly compared to other locations and conferences the Shingle Creek location is just dynamite. All the best hope to keep attending in years to come!

Associate Director - Design & Innovation, Global Development, Gilead

There is no better place to open the year than SCOPE Summit. Micah and the team curate an amazing program, and the community responds by showing up energized to connect and share. Between the busy sessions, buzzing exhibit hall and incredible hallway conversations, everyone leaves with a full tank!

Founder & Advisor, Clinical Innovation Partners LLC

Year after year, SCOPE continues to be the place where the most important conversations in clinical operations happen. After winning the Site Innovation Award this year, we were blown away by how many sponsors and sites approached us wanting to join on our mission of connecting patients searching for a clinical trial with their preferred site. There's a genuine desire across the industry to collaborate for site and patient benefit, and SCOPE is where that momentum builds.

Chief Growth Officer & Head of Americas, TrialScreen

This was my first SCOPE - the coordination and logistics have been simply great! Coming from Italy, this is something that I value a lot, for networking and learning sessions around the pharma industry. So well done to the CHI and SCOPE Team! As a speaker and attendee, this has been a great opportunity!

Sr Contracts Mgr, CSS, Catalyst Clinical Research Ltd

SCOPE provides a critical intersection for innovators and operators to share ideas, perspectives, and realities in an open format designed to drive opportunity. SCOPE is one of the best ways to understand our industry at a high level and then make the human connections that drive all meaningful change.

Founder & CEO, Circuit Clinical

SCOPE never fails to deliver on the quality of discussions, collection of industry leaders and super relevant agenda… and all with a dose of levity! I always value my time at SCOPE and was honored to participate in a keynote panel.

Chief Medical Officer, Commercial Healthcare and Life Sciences, Amazon Web Services

SCOPE 2026 was an engaging, impactful, resourceful, and networking event where clinical operation leaders of all levels can benefit and grow. The conference was undoubtedly a great success, filled with invaluable insights and connections.

VP, Boehringer Ingelheim Pharmaceuticals, Inc.

The impact of SCOPE continues to grow, and this year was a testament to that. The breadth and reach of thought leaders, decision makers, and key influencers means interesting and impactful conversations are happening every 10 feet and every 5 minutes. Even better, the insights and experiences showcased in the sessions continues to drive learnings in a way that’s difficult to replicate. There’s really no better way to kick off the year!

Chief Strategy Officer, Medidata Solutions

Been coming every year since the beginning and each event is better than the last - the amount of new talent, creative minds and fresh energy is the best way to start the year off!! If there is only one, comprehensive event you can afford to attend, it's SCOPE. Having been both a Pharma Sponsor and a Solution Provider, I have seen the benefits of SCOPE from both sides of the aisle. Whether it is learning from your peers, generating new leads, deepening current relationships, or finding creative synergies, SCOPE provides the fertile ground to do so. But you can't sit on the sidelines - you gotta show up and make it happen. The good news is that everyone is ready for you!

Chief Strategy Officer, Proofpilot

SCOPE 2026 was a reminder of how our industry is moving—from ideas to execution—and how collaboration across investigators, industry, and regulators is accelerating meaningful change in clinical research. I left this year's conference energized by the momentum behind innovative approaches and technologies aimed at solving incredibly challenges issues in our industry.

Vice President, Portfolio Management, TransCelerate

SCOPE is my favorite conference as it is the opportunity to explore all the facets of our industry, from clinical trial sites, technology and services organizations to our most important collaborator, the patient. You get that unique opportunity to hear from patients, industry experts and leaders. Great time to get reenergized for the important work that we all do every day.

COO, Parexel

Once again, wow! SCOPE was an amazing and well-curated conference. You bring so much creativity and energy into this event. Thank you again for this platform for our work.

Patient Advocate Lead, Proximity Health Solutions

SCOPE has always been the great connector of clinical research professionals. Each year seems to surpass the year before. And while new programming and tracks are added, my favorite is always the “hallway track” – the people you see and the casual conversations walking around the grounds of the hotel and conference center. You can’t put a price tag on those connections.

President, Praxis

SCOPE 2026 was my first time being there. Although overwhelming at first it became one of the most inspirational experiences of the last couple of years. It’s great to meet so many like-minded people all working hard to improve and accelerate the way we bring new treatments to patients. I left the conference energized, inspired, and with many new connections and ideas to bring back to my colleagues back in the office.

Trial Patient & Site Engagement Lead, Boehringer Ingelheim B.V.

As a first time SCOPE attendee, I immediately noticed that this conference would be different. With education and exchange tracks meeting needs of all stakeholders across the clinical trial value chain, I would recommend anyone seeking to improve how they design and execute trials to attend.

Medical Head Immunology North America, Sanofi

SCOPE was incredibly energizing this year. It was refreshing to step away from the day-to-day and connect with so many thoughtful leaders across clinical operations, data, and innovation. The conversations reinforced how much momentum there is around improving oversight, startup efficiency, and collaboration across sponsors and CROs. Grateful for the opportunity to reconnect with colleagues and build new relationships that will continue well beyond the conference.

Dir Strategic Solutions, Concinnity Co

The SCOPE conference is one of the best opportunities for sharing information and ideas within the pharmaceutical industry. The start of the year timing is perfect as most organizations have determined their path forward and are now sharing this information to others. The return on time investment for the conference is of great value.

CEO, Atorus Research

Similar to last year, SCOPE is a lot to take in, but at the end of the day, absolutely worth the time and investment. I have to commend the incredible work that goes into planning and organizing such a large conference with multiple tracks. The communications were very helpful, and the flexibility in accepting last-minute requests did not go unnoticed (like mine asking to be added to a TA workshop). The effort to get everyone engaged from the beginning to end was truly impressive.

Having been in the industry for nearly 30 years, primarily focused on market intelligence and insights, it was encouraging to hear companies finally moving beyond the hypothetical of being more patient-centric. Adapting and adopting new technologies – driven by AI, increasing community site presence in clinical studies, and more, were all hot topics. There is still a lot of work to be done in these areas, especially figuring out how to work better with sites by reducing redundant processes and resources (e.g., equipment). However, it was great to hear about companies (both pharma and tech) starting to break down silos to be more successful.

The passion in clinical research and development was palpable throughout the conference, and I could feel the buzz everywhere.

Thank you to you and the team for another successful SCOPE Summit!

Head of Market Intelligence, Corporate Strategy & Business Development, McKesson